⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11391912 | 1.00 | — | — | |
| SCHEMBL9534256 | 1.00 | — | — | |
| SCHEMBL13825859 | 0.84 | MAPT (0.42) | — | |
| SCHEMBL2464131 | 0.84 | MAPT (0.52) | — | |
| SCHEMBL2464133 | 0.84 | MAPT (0.52) | — | |
| SCHEMBL211077 | 0.79 | — | — | |
| SCHEMBL6157933 | 0.76 | — | — | |
| SCHEMBL8869650 | 0.75 | — | — | |
| SCHEMBL21654218 | 0.75 | — | — | |
| SCHEMBL10925589 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103280598-A | Lithium ion battery and electrolyte thereof | AMPEREX TECHNOLOGY LTD | 2013-09-04 | — | — | CN | claimed |
| EP-0485890-A2 | Use of 2,3-disubstituate 1-azolyl-propane for inhibiting the pathogenic growth phase of dimorph yeast cell | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-05-20 | — | — | EP | claimed |
| CN-117362662-A | Hyperbranched carbon-nitrogen heterocyclic resin and resin composition, prepreg, circuit substrate and printed circuit board thereof | 浙江华正新材料股份有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-103280598-A | Lithium ion battery and electrolyte thereof | AMPEREX TECHNOLOGY LTD | 2013-09-04 | — | — | CN | disclosed |
| US-5187288-A | Electrically neutral, photostable, narrow absorption and emission spectra | MOLECULAR PROBES, INC. (US) | 1993-02-16 | — | — | US | disclosed |
| EP-0485890-A2 | Use of 2,3-disubstituate 1-azolyl-propane for inhibiting the pathogenic growth phase of dimorph yeast cell | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-05-20 | — | — | EP | disclosed |
| EP-0485890-A2 | Use of 2,3-disubstituate 1-azolyl-propane for inhibiting the pathogenic growth phase of dimorph yeast cell | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-05-20 | — | — | EP | disclosed |
| CN-85107235-A | As the replacement cinnamyl-2 of anti-inflammatory agent, the manufacture method of 3-Dihydrobenzofuranes and analogue | — | 1987-04-01 | — | — | CN | disclosed |
| US-4243672-A | CARDIOVASCULAR DISORDERS; CARDIOTONIC AGENTS | PFIZER INC. (US) | 1981-01-06 | — | — | US | disclosed |
| EP-0009326-A2 | Pyrrolyl keto and amino acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them | Pfizer Limited (GB) | 1980-04-02 | — | — | EP | disclosed |